• Oto-rhino-laryngology and...
Price 10.50 €
• Toxic nodular goitre asso...
Price 5.50 €
• Voice prostheses: long-te...
Price 10.50 €
• Phoniatric management of ...
Price 8.50 €
• Combined transoral and su...
Price 10.50 €
• Migraine, neurone and ves...
Price 5.50 €
• Recurrent mandibular amel...
Price 12.50 €
• Influence of Platelet Ric...
Price 10.50 €
• Diagnostic value of fine-...
Price 8.50 €
• Evaluation of the handica...
Price 10.50 €
• Cataract surgery and its ...
Price 10.50 €
• Quality of life before an...
Price 10.50 €
• Velo-pharyngeal incompete...
Price 14.00 €
• Newborn and infant nasal ...
Price 5.50 €
• Covering of parotid and c...
Price 14.00 €
• Periphery, central and ps...
Price 10.50 €
• The pedicled musculo-cuta...
Price 8.50 €
• The symphonix symposium u...
Price 8.50 €
• The prevention of voice d...
Price 10.50 €
• Vocal effectiveness in sp...
Price 10.50 €
• Supra and infra hyoid mid...
Price 10.50 €
• External otitis...
Price 8.50 €
• Late metastasis from rena...
Price 8.50 €
• Formant structures of vow...
Price 10.50 €
• Post-operative evaluation...
Price 10.50 €
• Laryngeal schwannomas...
Price 5.50 €
• Observational study to as...
Price 14.00 €
• Vertebro and cranio veino...
Price 14.00 €
• Research in cancer : adva...
Price 5.50 €
• Benign tumors of the nasa...
Price 14.00 €
• Analysis of the possibili...
Price 8.50 €
• Fibrous dysplasia, a case...
Price 10.50 €
• International Conference ...
Price 5.50 €
• Carotid body paragangliom...
Price 8.50 €
• Notes on voice and speech...
Price 8.50 €
• Objective analysis of pos...
Price 8.50 €
• Prognostic value of mandi...
Price 10.50 €
• Interest of MIBI scintigr...
Price 10.50 €
• Protruding ears...
Price 8.50 €
• Time-intensity trade of b...
Price 10.50 €
• Parathyroid carcinoma: di...
Price 5.50 €
• Mucoepidermoid carcinomas...
Price 10.50 €
• Medical rhinoplasty: Rati...
Price 10.00 €
• Non-Hodgkin's lymphoma of...
Price 5.50 €
• Adenoid cystic carcinoma ...
Price 5.50 €
• CT scan, MR imaging and a...
Price 10.50 €
• Role of positron emission...
Price 15.00 €
• Explorations of the velum...
Price 14.00 €
Total Order 464.00 €
|
2019
N#
1
|
2018
N#
1
|
2
|
3
|
4
|
5
|
2017
N#
1
|
2
|
3
|
4
|
5
|
2016
N#
1
|
2
|
3
|
4
|
5
|
2015
N#
1
|
2
|
3
|
4
|
5
|
2014
N#
1
|
2
|
3
|
4
|
5
|
2013
N#
1
|
2
|
3
|
4
|
5
|
2012
N#
1
|
2
|
3
|
4
|
5
|
2011
N#
1
|
2
|
3
|
4
|
5
|
2010
N#
1
|
2
|
3
|
4
|
5
|
2009
N#
1
|
2
|
3
|
4
|
5
|
2008
N#
1
|
2
|
3
|
4
|
5
|
2007
N#
1
|
2
|
3
|
4
|
5
|
2006
N#
1
|
2
|
3
|
4
|
5
|
2005
N#
|
1
|
2
|
3
|
4
|
5
|
2004
N#
1
|
2
|
3
|
4
|
5
|
2003
N#
1
|
2
|
3
|
4
|
5
|
2002
N#
1
|
2
|
3
|
4
|
5
|
2001
N#
1
|
2
|
3
|
4
|
5
|
2000
N#
|
1
|
2
|
3
|
4
|
5
|
1999
N#
1
|
2
|
3
|
4
|
5
|
1998
N#
1
|
2
|
3
|
5
|
1997
N#
1
|
2
|
3
|
4
|
5
|
1996
N#
4
|
5
|
Click on the number of the review to see the content
|
|
List of all teaching bulletins CME.
|
|
Editor reading committee.
|
|
Select of books and press articles.
|
|
If you wish to adjust the size of the displayed characters, click in
the high menu on "Your account" and choose the desired size.
|
|
Issue N# 4 - 2001
RHINOLOGY
Mucosal melanomas of the head and neck. Experience of the Salah Azaiz Institute (Tunis).
Authors : Z. Oueslati, S. Touati, S. Gritli, A. El-May, F. Benna, H. Boussen, A. El-Khedim, M. Ferjaoui, A. Ladgham (Tunis)
Ref. : Rev Laryngol Otol Rhinol. 2001;122,4:237-240.
Article published in french 
Downloadable PDF document french
Summary :
The mucosal melanoma of the head and neck is rare and of late diagnosis. This retrospective study concerns 17 cases brought together in 30 years. Sex-ratio was of 1,1, the average age of 58 years. Tumoral seats were the following ones : nasal cavity and paranasal sinus (n=10), nasopharyngeal cavity (n=2), gingival seat (n=2), palate (n=1), laryngeal seat (n=1), middle ear (n=1). Tumoral extension was classified an follows: stage I: 52,9%, stage II: 17,6%, stage III: 29,4%. Melanomas were achromic in 23,5% of cases. On the therapeutic plan, 47,1% of the patients were treated in a purpose palliative because of the importance of the tumoral extension. Seven patients (41,2%) were treated surgically ; three among them received an additional radiotherapy for an insufficient tumoral excision or adenopathy in break capsular. Two patients (11,8%) were treated by exclusive radiotherapy. The rates of survival were 17,6% in 2 years, and 5,9% in 5 years. The average duration of survival was of 18,1 months. The causes of failure were essentially local and metastatic.
Price : 8.50 €
|
|
|
|
